NDT Advance Access originally published online on April 1, 2007
Nephrology Dialysis Transplantation 2007 22(7):1882-1890; doi:10.1093/ndt/gfm145
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis
1Division of Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile and 2Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain
Correspondence and offprint requests to: Sergio Mezzano, MD, Division Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile. Email: smezzano{at}uach.cl
| Abstract |
|---|
Background. Recent evidence in vitro and in vivo suggests that gremlin, a bone morphogenetic protein antagonist, is participating in tubular epithelial mesenchymal transition (EMT) in diabetic nephropathy as a downstream mediator of TGF-ß. Since EMT also occurs in parietal epithelial glomerular cells (PECs) leading to crescent formation, we hypothesized that gremlin could participate in this process. With this aim we studied its expression in 30 renal biopsies of patients with pauci-immune crescentic nephritis.
Methods. Gremlin was detected by in situ hybridization (ISH) and immunohistochemistry (IMH) and TGF-ß by ISH and Smads by southwestern histochemistry (SWH). Phosphorylated Smad2, CTGF, BMP-7, PCNA,
-SMA, synaptopodin, CD-68, and phenotypic markers of PECs (cytokeratin, E-cadherin), were detected by IMH. In cultured human monocytes, gremlin and CTGF induction by TGF-ß was studied by western blot.
Results. We observed strong expression of gremlin mRNA and protein in cellular and fibrocellular crescents corresponding to proliferating PECs and monocytes, in co-localization with TGF-ß. A marked over-expression of gremlin was also observed in tubular and infiltrating interstitial cells, correlating with tubulointerstitial fibrosis (r = 0.59; P < 0.01). A nuclear Smad activation in the same tubular cells, that are expressing TGF-ß and gremlin, was detected. In human cultured monocytes, TGF-ß induced gremlin production while CTGF expression was not detected.
Conclusion. We postulate that gremlin may play a role in the fibrous process in crescentic nephritis, both in glomerular crescentic and tubular epithelial cells. The co-localization of gremlin and TGF-ß expression found in glomeruli and tubular cells suggest that gremlin may be important in mediating some of the pathological effects of TGF-ß.
Keywords: BMP-7 antagonist; crescentic glomerulonephritis; epithelial mesenchymal transition (EMT); gremlin; TGF-ß; Smad
Received for publication: 13. 9.06
Accepted in revised form: 23. 2.07
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Turk, J. W. Leeuwis, J. Gray, S. V. Torti, K. M. Lyons, T. Q. Nguyen, and R. Goldschmeding BMP Signaling and Podocyte Markers Are Decreased in Human Diabetic Nephropathy in Association With CTGF Overexpression J. Histochem. Cytochem., July 1, 2009; 57(7): 623 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Roxburgh, J. J. Kattla, S. P. Curran, Y. M. O'Meara, C. A. Pollock, R. Goldschmeding, C. Godson, F. Martin, and D. P. Brazil Allelic Depletion of grem1 Attenuates Diabetic Kidney Disease Diabetes, July 1, 2009; 58(7): 1641 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jara, C. Chacon, M. E. Burgos, A. Droguett, A. Valdivieso, M. Ortiz, P. Troncoso, and S. Mezzano Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1121 - 1129. [Abstract] [Full Text] [PDF] |
||||


